泰达生物(08189)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

08189 泰达生物

未开盘 06-04 15:12:22

0.165

+0.002

+1.23%

最高0.170	最低0.163	成交量25.00万
今开0.163	昨收0.163	日振幅4.29%
总市值3.52亿	流通市值2.37亿	总股本21.34亿
成交额4.12万	换手率0.02%	流通股本14.36亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"08189","market":"HK","secType":"STK","nameCN":"泰达生物","latestPrice":0.165,"timestamp":1780557142193,"preClose":0.163,"halted":0,"volume":250000,"delay":0,"changeRate":0.01226993865030676,"floatShares":1436400000,"shares":2134000000,"eps":-0.043671,"marketStatus":"未开盘","change":0.002,"latestTime":"06-04 15:12:22","open":0.163,"high":0.17,"low":0.163,"amount":41245,"amplitude":0.042945,"askPrice":0.165,"askSize":15000,"bidPrice":0.155,"bidSize":60000,"shortable":0,"etf":0,"ttmEps":-0.048598,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780623000000},"marketStatusCode":0,"adr":0,"listingDate":1024329600000,"exchange":"SEHK","adjPreClose":0.163,"openAndCloseTimeList":[[1780536600000,1780545600000],[1780549200000,1780560000000]],"volumeRatio":0.072025,"lotSize":5000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08189/tweets","defaultTab":"tweets","newsList":[{"id":"1184275716","title":"泰达生物更新2026年5月股份变动月报表 股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1184275716","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184275716?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:42","pubTimestamp":1780479775,"startTime":"0","endTime":"0","summary":"天津泰达生物医学工程股份有限公司于2026年06月03日发布2026年5月的股份变动月报表，覆盖2026年5月1日至5月31日期间公司股份状况。月报显示，泰达生物在本报告期内未进行任何新增股份发行或股本减少，也无股份回购、注销或库藏股操作。泰达生物在公告中确认公司已充分满足香港联交所的最低公众持股量要求，并表示上述事项均已履行相关法律法规以及香港联交所《上市规则》的规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172418586","title":"泰达生物更新4月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1172418586","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172418586?lang=zh_cn&edition=full","pubTime":"2026-05-04 10:02","pubTimestamp":1777860125,"startTime":"0","endTime":"0","summary":"天津泰达生物医学工程股份有限公司于2026年5月4日发布截至2026年4月30日的股份变动月报表。报告显示，公司当月未进行新增股份发行、购回或注销，整体股本结构保持稳定。根据公告，泰达生物截至2026年4月30日的注册股本总额为人民币213,390,000元，较上月无变化。报告期内，泰达生物未发生任何与股份期权计划或股权激励相关的股份授予、行使及失效事宜，也未进行任何形式的股份回购或注销操作。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165977439","title":"泰达生物（08189）2025年营收上升35.68%，多元化业务并行下亏损扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=1165977439","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165977439?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:21","pubTimestamp":1777551696,"startTime":"0","endTime":"0","summary":"天津泰达生物医学工程股份有限公司公布截至2025年12月31日止年度主要经营和财务情况，显示整体收入显著增长，但亏损幅度有所扩大。公司业务主要聚焦肥料产品和AI生命健康两大板块，持续推进产业链整合及跨领域协同。每股亏损由2024年度的人民币1.46分上升至4.37分。资产负债方面，截至2025年12月31日，资产总额约人民币2.65亿元，负债总额约人民币2.62亿元，股东应占权益约人民币1,222.4万元，较上年同期有所下滑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"泰达生物（08189）2025年营收上升35.68%，多元化业务并行下亏损扩大","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631632386","title":"泰达生物(08189)：夏瑞哲调任为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2631632386","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631632386?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:18","pubTimestamp":1777551516,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰达生物(08189)发布公告，公司执行董事夏瑞哲先生因受其持有的香港证券及期货事务监察委员会9号资产管理人RO牌照相关监管限制，申请由公司执行董事调任为非执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08189","BK1113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173850069","title":"泰达生物3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1173850069","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173850069?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:17","pubTimestamp":1775042240,"startTime":"0","endTime":"0","summary":"天津泰达生物医学工程股份有限公司于2026年4月1日发布3月股份变动月报表，报告期截至2026年3月31日。根据公告披露，公司当月各类股份及注册股本均无新增发行或注销情况。公司同时确认当月无回购或库藏股行动，也未发生任何股份期权、权证或可换股票据的变动。公司在公告中声明，已遵守香港联合交易所有限公司《上市规则》及其他相关法律规定，并由董事孙莉签署确认。综上所述，截至3月31日，泰达生物股本结构保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624364075","title":"泰达生物(08189)：Lynn Li获委任为公司联席行政总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2624364075","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624364075?lang=zh_cn&edition=full","pubTime":"2026-04-01 00:22","pubTimestamp":1774974159,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰达生物(08189)发布公告，Lynn Li女士已获委任为公司联席行政总裁及孙莉女士已由公司的行政总裁调任为公司的联席行政总裁，自2026年3月31日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1113","08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624536528","title":"泰达生物(08189)发布年度业绩 股东应占亏损9082万元 同比扩大226.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624536528","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624536528?lang=zh_cn&edition=full","pubTime":"2026-04-01 00:10","pubTimestamp":1774973418,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰达生物(08189)发布截至2025年12月31日止年度业绩，集团营业额人民币5.23亿元，同比增长35.67%;股东应占亏损9082万元，同比扩大226.67%;每股亏损4.37分。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"泰达生物(08189)发布年度业绩 股东应占亏损9082万元 同比扩大226.67%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1113","08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191221420","title":"泰达生物(08189.HK)任命李琳为联席首席执行官 孙莉再度获委任联席CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1191221420","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191221420?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:21","pubTimestamp":1774966873,"startTime":"0","endTime":"0","summary":"天津泰达生物医学工程股份有限公司宣布，公司已正式任命李琳为联席首席执行官，与孙莉共同担任公司最高管理职务。同时，孙莉亦再度获委任为联席首席执行官，继续发挥其领导作用。\n此次管理层调整旨在优化公司治理结构，强化战略执行能力。李琳的加入将为公司带来新的管理视角和行业经验，而孙莉的连任则确保了领导团队的连续性和稳定性。这一人事安排体现了公司对业务发展和管理效能的双重重视，有望为泰达生物的未来发展注入新的活力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08189","BK1113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120096620","title":"泰达生物：预计2025年度股东应占亏损扩大至约8,500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120096620","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120096620?lang=zh_cn&edition=full","pubTime":"2026-03-29 18:11","pubTimestamp":1774779099,"startTime":"0","endTime":"0","summary":"泰达生物29日发布盈利警告称，预计截至2025年12月31日止年度将录得约8,500万元人民币的股东应占亏损，而上一财年公司录得亏损2,780.22万元人民币。按可比口径计算，本年度亏损规模预计同比扩大约205%。公告同时提示，相关数据基于董事会对集团截至报告期业绩的初步评估，最终经审计结果可能有所调整。公司计划于2026年3月底前披露经审核的2025年度业绩。泰达生物建议投资者及股东在买卖公司股份时保持审慎，并关注后续公告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623353708","title":"泰达生物(08189)发盈警 预计年度股东应占亏损约8500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623353708","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623353708?lang=zh_cn&edition=full","pubTime":"2026-03-29 18:10","pubTimestamp":1774779038,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰达生物(08189)发布公告，本集团预计截至2025年12月31日止年度将录得股东应占亏损约8500万元人民币，而2024年12月31日止年度股东应占亏损为2780.22万元人民币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"泰达生物(08189)发盈警 预计年度股东应占亏损约8500万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1113","08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618133203","title":"泰达生物盘中异动 快速跳水6.67%报0.280港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618133203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618133203?lang=zh_cn&edition=full","pubTime":"2026-03-12 10:04","pubTimestamp":1773281050,"startTime":"0","endTime":"0","summary":"2026年03月12日早盘10时04分，泰达生物股票出现波动，股价快速下挫6.67%。截至发稿，该股报0.280港元/股，成交量26.5万股，换手率0.02%，振幅5.00%。资金方面，该股资金流入1.885万港元，流出5.225万港元。泰达生物股票所在的化肥农药行业中，整体涨幅为0.02%。其相关个股中，中海石油化学、大成生化科技、中化化肥涨幅较大，振幅较大的相关个股有中海石油化学、大成生化科技、泰达生物，振幅分别为7.01%、6.56%、5.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312100410a4628e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312100410a4628e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1113","08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199896242","title":"天津泰达生物医学工程（08189）2026年2月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1199896242","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199896242?lang=zh_cn&edition=full","pubTime":"2026-03-02 10:25","pubTimestamp":1772418334,"startTime":"0","endTime":"0","summary":"天津泰达生物医学工程股份有限公司于2026年3月2日发布2026年2月股份变动月报表。公告显示，公司注册股本及已发行股份在当月保持不变。合计已发行股份总数2,133,900,000股，面值均为每股人民币0.1元。公告披露，2026年2月期间公司未进行新增发行、购回、注销或任何库藏股变动；同时未有任何股份期权、可换股票据或其他发行人股份相关权证与协议发生变动。公告由公司董事孙莉签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613737865","title":"泰达生物盘中异动 大幅下跌6.25%报0.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613737865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613737865?lang=zh_cn&edition=full","pubTime":"2026-02-23 10:04","pubTimestamp":1771812266,"startTime":"0","endTime":"0","summary":"2026年02月23日早盘10时04分，泰达生物股票出现波动，股价快速下挫6.25%。截至发稿，该股报0.300港元/股，成交量31万股，换手率0.02%，振幅6.25%。资金方面，该股资金流入3100港元，流出3.8125万港元。泰达生物股票所在的化肥农药行业中，整体涨幅为0.05%。其相关个股中，玖源集团、中化化肥、米高集团涨幅较大，振幅较大的相关个股有玖源集团、泰达生物、中国心连心化肥，振幅分别为111.76%、3.13%、2.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022310042697a6afd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022310042697a6afd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1113","08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612254812","title":"泰达生物盘中异动 股价大跌7.58%报0.305港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612254812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612254812?lang=zh_cn&edition=full","pubTime":"2026-02-20 14:19","pubTimestamp":1771568379,"startTime":"0","endTime":"0","summary":"2026年02月20日下午盘14时19分，泰达生物股票出现异动，股价快速下跌7.58%。截至发稿，该股报0.305港元/股，成交量34万股，换手率0.02%，振幅9.09%。资金方面，该股资金流入8250港元，流出5.1275万港元。泰达生物股票所在的化肥农药行业中，整体跌幅为0.09%。其相关个股中，富一国际控股、中海石油化学、东光化工涨幅较大，振幅较大的相关个股有泰达生物、米高集团、富一国际控股，振幅分别为9.09%、4.13%、4.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022014193997a68d0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022014193997a68d0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1113","08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611195961","title":"泰达生物股价逆势下跌，AI医疗业务商业化待验证","url":"https://stock-news.laohu8.com/highlight/detail?id=2611195961","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611195961?lang=zh_cn&edition=full","pubTime":"2026-02-14 14:25","pubTimestamp":1771050308,"startTime":"0","endTime":"0","summary":"股票近期走势2026年2月11日，泰达生物股价近7日累计下跌11.43%，同期AI医疗板块微涨0.94%，呈现逆势走弱态势。业务进展情况公司AI医疗业务仍处于研发投入期，尚未形成规模收入。行业政策与环境AI医疗行业政策利好频出，但市场资金更倾向于已实现商业化落地的龙头企业。公司状况2025年12月，泰达生物在“第十四届上市公司发展年会”上获“港股最具投资潜力上市公司”荣誉，反映市场对其AI医疗技术布局的长期期待。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260214142811a6fa6beb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260214142811a6fa6beb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1113","08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610618854","title":"泰达生物盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610618854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610618854?lang=zh_cn&edition=full","pubTime":"2026-02-10 11:15","pubTimestamp":1770693321,"startTime":"0","endTime":"0","summary":"2026年02月10日早盘11时15分，泰达生物股票出现异动，股价急速上涨5.00%。截至发稿，该股报0.315港元/股，成交量24.5万股，换手率0.02%，振幅5.00%。泰达生物股票所在的化肥农药行业中，整体涨幅为0.04%。其相关个股中，泰达生物、米高集团、中国心连心化肥涨幅较大，振幅较大的相关个股有泰达生物、中国心连心化肥、米高集团，振幅分别为5.00%、4.14%、3.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210111521954085f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210111521954085f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1113","08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610683454","title":"泰达生物盘中异动 早盘股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610683454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610683454?lang=zh_cn&edition=full","pubTime":"2026-02-09 11:14","pubTimestamp":1770606850,"startTime":"0","endTime":"0","summary":"2026年02月09日早盘11时14分，泰达生物股票出现波动，股价急速下挫5.63%。截至发稿，该股报0.335港元/股，成交量52.5万股，换手率0.04%，振幅7.04%。泰达生物股票所在的化肥农药行业中，整体跌幅为0.01%。其相关个股中，中海石油化学、中化化肥、米高集团涨幅较大，振幅较大的相关个股有泰达生物、中国心连心化肥、中海石油化学，振幅分别为7.04%、5.47%、3.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209111410a6e431d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209111410a6e431d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08189","BK1113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608181455","title":"泰达生物02月02日主力净流出20.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608181455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608181455?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:15","pubTimestamp":1770020139,"startTime":"0","endTime":"0","summary":"02月02日，泰达生物股价收平报0.35元，成交金额62.0万元，换手率0.13%，振幅7.14%，量比0.82。泰达生物今日主力资金净流出20.5万元，上一交易日主力净流出0万元。该股近5个交易日上涨16.67%，主力资金累计净流出20.5万元；近20日主力资金累计净流出80.7万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161931a4727b97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161931a4727b97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08189","BK1113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608814554","title":"泰达生物盘中异动 临近午盘股价大跌5.71%报0.330港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608814554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608814554?lang=zh_cn&edition=full","pubTime":"2026-02-02 11:59","pubTimestamp":1770004792,"startTime":"0","endTime":"0","summary":"2026年02月02日临近午盘11时59分，泰达生物股票出现异动，股价快速下挫5.71%。截至发稿，该股报0.330港元/股，成交量79.5万股，换手率0.06%，振幅5.71%。资金方面，该股资金流入2.2425万港元，流出21.645万港元。泰达生物股票所在的化肥农药行业中，整体跌幅为0.35%。其相关个股中，东光化工、富一国际控股、玖源集团涨幅较大，振幅较大的相关个股有中国心连心化肥、大成生化科技、米高集团，振幅分别为7.13%、5.97%、4.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202115953a4719a9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202115953a4719a9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1113","08189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139695413","title":"天津泰达生物医学（08189）1月无新增股份发行或变动，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1139695413","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139695413?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:46","pubTimestamp":1770000370,"startTime":"0","endTime":"0","summary":"天津泰达生物医学工程股份有限公司于2026年2月2日披露2026年1月股份变动月报表。公告显示，截至2026年1月31日，公司注册股本总额213,390,000人民币，较上月保持不变。公司表示已遵守香港联交所《上市规则》及相关法律法规，确认本月所有与股份相关的事宜均获得董事会正式批准。截至本月末，股本结构保持稳定，无新增或回购活动。该公告由公司董事孙莉签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08189"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioteda.com","stockEarnings":[{"period":"1week","weight":-0.0782},{"period":"1month","weight":-0.3774},{"period":"3month","weight":-0.45},{"period":"6month","weight":-0.45},{"period":"1year","weight":-0.5875},{"period":"ytd","weight":-0.459}],"compareEarnings":[{"period":"1week","weight":0.0099},{"period":"1month","weight":-0.0249},{"period":"3month","weight":-0.0196},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0676},{"period":"ytd","weight":-0.0147}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"天津泰达生物医学工程股份有限公司是一家主要从事生物复合肥料产品的制造及销售的中国公司。该公司主要通过两个分部运营其业务。肥料产品分部从事制造及销售生物复合肥料产品（包括活性肥、不同配方的氮、磷及钾复合肥）、提供仓储服务以及肥料产品的加工及许可。养老及保健服务分部从事提供综合养老及保健服务，包括租赁老年人设备。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.541667,"avgChangeRate":0.014438},{"month":2,"riseRate":0.541667,"avgChangeRate":-0.007724},{"month":3,"riseRate":0.458333,"avgChangeRate":0.035341},{"month":4,"riseRate":0.208333,"avgChangeRate":0.000187},{"month":5,"riseRate":0.5,"avgChangeRate":0.09602},{"month":6,"riseRate":0.375,"avgChangeRate":-0.009573},{"month":7,"riseRate":0.375,"avgChangeRate":-0.0284},{"month":8,"riseRate":0.625,"avgChangeRate":0.166446},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.003149},{"month":10,"riseRate":0.208333,"avgChangeRate":-0.065134},{"month":11,"riseRate":0.291667,"avgChangeRate":0.035483},{"month":12,"riseRate":0.25,"avgChangeRate":0.00692}],"exchange":"SEHK","name":"泰达生物","nameEN":"TEDA BIOMEDICAL"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰达生物(08189)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰达生物(08189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰达生物,08189,泰达生物股票,泰达生物股票老虎,泰达生物股票老虎国际,泰达生物行情,泰达生物股票行情,泰达生物股价,泰达生物股市,泰达生物股票价格,泰达生物股票交易,泰达生物股票购买,泰达生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰达生物(08189)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰达生物(08189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}